Filters
Filters

 

Resource Type
Topic
Show (22)
Cancel
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
July 23, 2024
Read More
Metrion Biosciences enhances high-throughput screening services with access to Enamine compound libraries
April 11, 2024
Read More
Metrion Biosciences strengthens team with 3 key appointments
March 11, 2024
Read More
Metrion Biosciences closes £3.7m new equity financing
December 20, 2023
Read More
Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Testing Service
August 1, 2023
Read More
Metrion Biosciences expands senior leadership team with appointments of Dr Robert Kirby as COO and Dr Edward Stevens as CSO
July 6, 2023
Read More
Metrion Biosciences appoints Dr Steve Jenkinson as VP, Drug Discovery and Safety Assessment to strengthen US Operations
June 12, 2023
Read More
Metrion Biosciences and the KCNC1 Foundation collaborate on development of new ion channel modulators for ultra-rare genetic disorder
December 7, 2022
Read More
Metrion Biosciences invests in new High Throughput Screening capability and expanded facilities
November 30, 2022
Read More
Metrion Biosciences appoints Dr Benedetta Montagnini as head of European Business Development
June 9, 2022
Read More
1 2 3
Metrion Biosciences

Let’s work together

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.
Contact us for a quote or discussion
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
Copyright © 2024 Metrion. All rights reserved | Privacy notice | Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram